Sterne JA, Hernn MA, Reeves BC, et al
Indirect comparisons using network meta-analysis suggest tirzepatide 15 mg produces approximately 5, 6 percentage points greater weight loss than semaglutide 2.4 mg, but trial populations differ in ways that complicate direct comparison
patients who did not work with a Nourish RD 60% of Nourish patients who discontinued GLP-1s found Nourish helpful in maintaining their weight post-treatment Nourish programs drive meaningful cost savings for employers ($2.1M for an employer with 10K employees) by avoiding wasted spend and optimizing for greater results These outcomes show that pairing GLP-1 treatment with personalized, insurance-covered nutrition care from Nourish makes a measurable difference in long-term results
Consider smaller, nutrient-dense meals and discuss supplementation with your provider based on baseline lab work before and during treatment
It also has a proven heart benefit: in a large trial, it reduced heart attacks and strokes by 20%
Doctors and scientists say there is a lack of sufficient scientific evidence for the safety of non-FDA-approved injectable peptides marketed for wellness